Understanding the Associations between High-Dose Methotrexate Pharmacokinetics and the Risk of Adverse Events in Children and Adolescents with Down Syndrome Associated High-Risk Acute Lymphoblastic Leukemia

被引：0
|
作者：
Westmoreland, Kate D. [1 ,2 ]
Taylor, Zachary L. [3 ,4 ]
Miller, Tamara P. [5 ,6 ]
Chavana, Ashley [7 ]
Rabin, Karen R. [8 ,9 ,10 ]
Brown, Austin L. [11 ]
Bernhardt, Melanie Brooke [12 ]
Schafer, Eric S. [8 ,9 ,10 ]
O'Brien, Maureen M. [13 ,14 ]
Castellino, Sharon M. [5 ,15 ]
Ramsey, Laura B. [3 ,4 ]
机构：
[1] Univ North Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[3] Cincinnati Childrens Hosp, Dept Pediat, Div Pediat Hematol Oncol, Med Ctr, Chapel Hill, NC 27599 USA
[4] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Hematol, Cincinnati, OH USA
[5] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Cincinnati, OH USA
[6] Emory Univ, Childrens Healthcare Atlanta, Sch Med, Atlanta, GA USA
[7] Baylor Coll Med, Houston, TX USA
[8] Baylor Coll Med, Dept Pediat, Div Hematol Oncol, Houston, TX USA
[9] Texas Childrens Hosp, Canc Ctr, Houston, TX USA
[10] Texas Childrens Hosp, Div Pediat Hematol Oncol, Houston, TX USA
[11] Baylor Coll Med, Dept Pediat, Houston, TX USA
[12] St Jude Childrens Res Hosp, Dept Pharm & Pharmaceut Sci, Memphis, TN USA
[13] Colorado Childrens Hosp, Aurora, CO USA
[14] Univ Colorado, Sch Med, Aurora, CO USA
[15] Emory Univ, Sch Med, Dept Pediat, Div Hematol Oncol & Bone Marrow Transplant, Decatur, GA USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-211870
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1438 / 1439
页数：2
相关论文
共 50 条
  • [41] A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma
    Pappo, AS
    Bowman, LC
    Furman, WL
    Rao, BN
    Kun, LE
    Jenkins, JJ
    Crom, WR
    Luo, XL
    Kaste, SC
    Avery, L
    Meyer, WH
    Shapiro, DN
    Crist, WM
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (05) : 438 - 442
  • [42] Effect of Body Fat on Population Pharmacokinetics of High-Dose Methotrexate in Pediatric Patients With Acute Lymphoblastic Leukemia
    Orgel, Etan
    Nabais, Teresa
    Douglas, Christopher
    Mittelman, Steven D.
    Neely, Michael
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (06): : 755 - 762
  • [43] Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients
    Rahmayanti, Siti Utami
    Amalia, Riezki
    Rusdiana, Taofik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (02) : 141 - 155
  • [44] Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia
    EL-Khodary, Noha M.
    EL-Haggar, Sahar M.
    Eid, Manal A.
    Ebeid, Emad N.
    MEDICAL ONCOLOGY, 2012, 29 (03) : 2053 - 2062
  • [45] Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia -: A logistic regression analysis
    Rask, C
    Albertioni, F
    Bentzen, SM
    Schroeder, H
    Peterson, C
    ACTA ONCOLOGICA, 1998, 37 (03) : 277 - 284
  • [46] Medium and high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia (ALL)
    Hedavatiasl, Amirabas
    Darbandi, Bahram
    Vossough, Parvaneh
    Faranoush, Mohammad
    Golpayegani, Mohammad Reza
    Zangooie, Rokhsaneh
    Yazdi, Fatemeh
    Rafsanjani, Khadijeh Arjmandi
    Ansari, Shahla
    Zarrabi, Mohammad
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 490 - 491
  • [47] Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia
    Noha M. EL-Khodary
    Sahar M. EL-Haggar
    Manal A. Eid
    Emad N. Ebeid
    Medical Oncology, 2012, 29 : 2053 - 2062
  • [48] Assessment of Renal Function During High-Dose Methotrexate Treatment in Children With Acute Lymphoblastic Leukemia
    Ylinen, Elisa
    Jahnukainen, Kirsi
    Saarinen-Pihkala, Ulla M.
    Jahnukainen, Timo
    PEDIATRIC BLOOD & CANCER, 2014, 61 (12) : 2199 - 2202
  • [49] Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia - a logistic regression analysis
    Acta Oncol, 3 (277-284):
  • [50] CNS PROPHYLAXIS WITH HIGH DOSE METHOTREXATE IN HIGH-RISK CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA
    COHEN, IJ
    ZAIZOV, R
    MATOTH, Y
    PEDIATRIC RESEARCH, 1978, 12 (01) : 65 - 65
12345